Abstract
Migraine is the most prevalent disabling neurological disorder. The management of patients with migraine has been hampered by lack of effective and well-tolerated acute and preventive therapies. Based on improved insights into the basic mechanisms of migraine, new and targeted treatments are currently undergoing large-scale testing. Among the most promising agents for migraine prevention are humanized antibodies against calcitonin gene-related peptide (CGRP) or the CGRP receptor. If proven effective, these new treatments may emerge to improve the lives of millions of individuals worldwide disabled by migraine.
| Translated title of the contribution | Basic mechanisms of migraine and new methods of treatment |
|---|---|
| Original language | Danish |
| Article number | V07160507 |
| Journal | Ugeskrift for Laeger |
| Volume | 178 |
| Number of pages | 5 |
| ISSN | 0041-5782 |
| Publication status | Published - 2016 |
Keywords
- Journal Article
- English Abstract